KALA BIO, Inc. — Income Charts
16 quarters of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-100.0% -$2M
$0
Cost of Revenue
$241K
R&D↑+87.1% +$3M
$5M
SG&A↓-75.7% -$18M
$6M
D&A↓-62.3% -$132K
$80K
Operating Income↑+44.1% +$12M
$-15M
EBITDA↓-62.3% -$132K
$80K
Interest Expense↓-24.0% -$499K
$2M
Interest Income↑+2850.0% +$342K
$354K
Tax Provision
$0
Net Income↑+203.4% +$57M
$29M
Operating Margin↓-2618.8pts
-3468.8%
Net Margin↑+7839.2pts
6922.1%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+0.6pts
5.4%
Operating Lease Cost↓-86.1% -$62K
$10K
Revenue YoY Variation↓-82.9pts
-100.0%
Income YoY Variation↑+45.0pts
44.1%
Revenue QoQ Variation↓-60.5pts
-100.0%
Income QoQ Variation↑+33.7pts
43.9%